The estimated Net Worth of Catherine M Burzik is at least 2.21 百万$ dollars as of 19 November 2021. Ms. Burzik owns over 1,660 units of Becton Dickinson & Co stock worth over 1,857,134$ and over the last 13 years she sold BDX stock worth over 0$. In addition, she makes 349,676$ as Independent Director at Becton Dickinson & Co.
Catherine has made over 3 trades of the Becton Dickinson & Co stock since 2018, according to the Form 4 filled with the SEC. Most recently she bought 1,660 units of BDX stock worth 50,248$ on 19 November 2021.
The largest trade she's ever made was buying 1,660 units of Becton Dickinson & Co stock on 19 November 2021 worth over 50,248$. On average, Catherine trades about 60 units every 33 days since 2011. As of 19 November 2021 she still owns at least 7,947 units of Becton Dickinson & Co stock.
You can see the complete history of Ms. Burzik stock trades at the bottom of the page.
Catherine M. Burzik serves as Independent Director of the Company. From 2006 until the sale of the company in 2012, she served as President and Chief Executive Officer of Kinetic Concepts, Inc., a medical device company specializing in the fields of wound care and regenerative medicine. Prior thereto, she was President of Applied Biosystems and President of Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company. Ms. Burzik also is a director of Haemonetics Corporation. Ms. Burzik is a seasoned executive in the healthcare industry, having led major medical device, diagnostic, diagnostic imaging and life sciences businesses. She contributes strong strategic, product development and leadership expertise, and extensive knowledge of the global healthcare field.
As the Independent Director of Becton Dickinson & Co, the total compensation of Catherine Burzik at Becton Dickinson & Co is 349,676$. There are 19 executives at Becton Dickinson & Co getting paid more, with Vincent Forlenza having the highest compensation of 16,014,600$.
Catherine Burzik is 69, she's been the Independent Director of Becton Dickinson & Co since 2013. There are 1 older and 31 younger executives at Becton Dickinson & Co. The oldest executive at Becton Dickinson & Co. is Marshall Larsen, 71, who is the Lead Independent Director.
Catherine's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.
Over the last 22 years, insiders at Becton Dickinson & Co have traded over 106,782,599$ worth of Becton Dickinson & Co stock and bought 23,860 units worth 1,771,828$ . The most active insiders traders include Edward J Ludwig、William M Brown、Vincent A Forlenza. On average, Becton Dickinson & Co executives and independent directors trade stock every 20 days with the average trade being worth of 4,349,205$. The most recent stock trade was executed by Roland Goette on 14 August 2024, trading 5,295 units of BDX stock currently worth 701,799$.
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
Becton Dickinson & Co executives and other stock owners filed with the SEC include: